<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31859421</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-1136</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Glia</Title><ISOAbbreviation>Glia</ISOAbbreviation></Journal><ArticleTitle>Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1165</StartPage><EndPage>1181</EndPage><MedlinePgn>1165-1181</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/glia.23768</ELocationID><Abstract><AbstractText>Distal axonopathy is a recognized pathological feature of amyotrophic lateral sclerosis (ALS). In the peripheral nerves of ALS patients, motor axon loss elicits a Wallerian-like degeneration characterized by denervated Schwann cells (SCs) together with immune cell infiltration. However, the pathogenic significance of denervated SCs accumulating following impaired axonal growth in ALS remains unclear. Here, we analyze SC phenotypes in sciatic nerves of ALS patients and paralytic SOD1<sup>G93A</sup> rats, and identify remarkably similar and specific reactive SC phenotypes based on the pattern of S100&#x3b2;, GFAP, isolectin and/or p75<sup>NTR</sup> immunoreactivity. Different subsets of reactive SCs expressed colony-stimulating factor-1 (CSF1) and Interleukin-34 (IL-34) and closely interacted with numerous endoneurial CSF-1R-expressing monocyte/macrophages, suggesting a paracrine mechanism of myeloid cell expansion and activation. SCs bearing phagocytic phenotypes as well as endoneurial macrophages expressed stem cell factor (SCF), a trophic factor that attracts and activates mast cells through the c-Kit receptor. Notably, a subpopulation of Ki67+ SCs expressed c-Kit in the sciatic nerves of SOD1<sup>G93A</sup> rats, suggesting a signaling pathway that fuels SC proliferation in ALS. c-Kit+ mast cells were also abundant in the sciatic nerve from ALS donors but not in controls. Pharmacological inhibition of CSF-1R and c-Kit with masitinib in SOD1<sup>G93A</sup> rats potently reduced SC reactivity and immune cell infiltration in the sciatic nerve and ventral roots, suggesting a mechanism by which the drug ameliorates peripheral nerve pathology. These findings provide strong evidence for a previously unknown inflammatory mechanism triggered by SCs in ALS peripheral nerves that has broad application in developing novel therapies.</AbstractText><CopyrightInformation>&#xa9; 2019 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trias</LastName><ForeName>Emiliano</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7187-511X</Identifier><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kovacs</LastName><ForeName>Mari&#xe1;ngeles</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Peter H</ForeName><Initials>PH</Initials><Identifier Source="ORCID">0000-0001-9391-7464</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, Alabama.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Birmingham Veterans Affairs Medical Center, Birmingham, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, Alabama.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Birmingham Veterans Affairs Medical Center, Birmingham, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Yuri</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varela</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibarburu</LastName><ForeName>Sof&#xed;a</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moura</LastName><ForeName>Ivan C</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Imagine Institute, H&#xf4;pital Necker, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paris Descartes-Sorbonne Paris Cit&#xe9; University, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CNRS ERL 8254, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Excellence GR-Ex, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equipe Lab&#xe9;lis&#xe9;e par la Ligue Nationale contre le cancer, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermine</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Imagine Institute, H&#xf4;pital Necker, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paris Descartes-Sorbonne Paris Cit&#xe9; University, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CNRS ERL 8254, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Excellence GR-Ex, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equipe Lab&#xe9;lis&#xe9;e par la Ligue Nationale contre le cancer, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AB Science, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Hematology, Necker Hospital, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre national de r&#xe9;f&#xe9;rence des mastocytoses (CEREMAST), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beckman</LastName><ForeName>Joseph S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Linus Pauling Institute, Department of Biochemistry and Biophysics, Environmental Health Sciences Center, Oregon State University, Corvallis, Oregon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbeito</LastName><ForeName>Luis</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3047-232X</Identifier><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 NS111275</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS092651</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA013148</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX004419</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX001148</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Glia</MedlineTA><NlmUniqueID>8806785</NlmUniqueID><ISSNLinking>0894-1491</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000628668">CSF1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C529076">IL34 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007378">Interleukins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019089">Stem Cell Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>81627-83-0</RegistryNumber><NameOfSubstance UI="D016173">Macrophage Colony-Stimulating Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007378" MajorTopicYN="N">Interleukins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016173" MajorTopicYN="N">Macrophage Colony-Stimulating Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055647" MajorTopicYN="N">Rats, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012583" MajorTopicYN="N">Schwann Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019089" MajorTopicYN="N">Stem Cell Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Schwann cells</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">masitinib</Keyword><Keyword MajorTopicYN="N">peripheral nerve pathology</Keyword><Keyword MajorTopicYN="N">tyrosine kinase receptors</Keyword></KeywordList><CoiStatement>Conflict of interest statement. OH is a co-founder and shareholder of AB science. Others have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31859421</ArticleId><ArticleId IdType="mid">NIHMS1581616</ArticleId><ArticleId IdType="pmc">PMC7269115</ArticleId><ArticleId IdType="doi">10.1002/glia.23768</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anastassiadis T, Deacon SW, Devarajan K, Ma H, &amp; Peterson JR (2011). Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol, 29(11), 1039&#x2013;1045. doi:10.1038/nbt.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2017</ArticleId><ArticleId IdType="pmc">PMC3230241</ArticleId><ArticleId IdType="pubmed">22037377</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour D, Tremblay E, Martineau E, Julien JP, &amp; Robitaille R. (2015). Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model. J Neurosci, 35(2), 688&#x2013;706. doi:10.1523/JNEUROSCI.1379-14.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1379-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605374</ArticleId><ArticleId IdType="pubmed">25589763</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigbee JW, Yoshino JE, &amp; DeVries GH (1987). Morphological and proliferative responses of cultured Schwann cells following rapid phagocytosis of a myelin- enriched fraction. J Neurocytol, 16(4), 487&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">3681350</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulakirba S, Pfeifer A, Mhaidly R, Obba S, Goulard M, Schmitt T, &#x2026; Jacquel A. (2018). IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential. Sci Rep, 8(1), 256. doi:10.1038/s41598-017-18433-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-18433-4</ArticleId><ArticleId IdType="pmc">PMC5762882</ArticleId><ArticleId IdType="pubmed">29321503</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosius Lutz A, Chung WS, Sloan SA, Carson GA, Zhou L, Lovelett E, &#x2026; Barres BA (2017). Schwann cells use TAM receptor-mediated phagocytosis in addition to autophagy to clear myelin in a mouse model of nerve injury. Proc Natl Acad Sci U S A, 114(38), E8072&#x2013;E8080. doi:10.1073/pnas.1710566114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1710566114</ArticleId><ArticleId IdType="pmc">PMC5617301</ArticleId><ArticleId IdType="pubmed">28874532</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari ML, Garcia-Ayllon MS, Ciura S, Saez-Valero J, &amp; Kabashi E. (2016). Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase. Front Mol Neurosci, 9, 160. doi:10.3389/fnmol.2016.00160</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00160</ArticleId><ArticleId IdType="pmc">PMC5187284</ArticleId><ArticleId IdType="pubmed">28082868</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YW, &amp; Winkelstein BA (2011). Schwann cell proliferation and macrophage infiltration are evident at day 14 after painful cervical nerve root compression in the rat. J Neurotrauma, 28(12), 2429&#x2013;2438. doi:10.1089/neu.2011.1918</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2011.1918</ArticleId><ArticleId IdType="pubmed">21787151</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitu V, Gokhan S, Nandi S, Mehler MF, &amp; Stanley ER (2016). Emerging Roles for CSF-1 Receptor and its Ligands in the Nervous System. Trends Neurosci, 39(6), 378&#x2013;393. doi:10.1016/j.tins.2016.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2016.03.005</ArticleId><ArticleId IdType="pmc">PMC4884457</ArticleId><ArticleId IdType="pubmed">27083478</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, Phatnani H, Kuligowski M, Tapia JC, Carrasco MA, Zhang M, &#x2026; Carroll, M. C. (2009). Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc Natl Acad Sci U S A, 106(49), 20960&#x2013;20965. doi:10.1073/pnas.0911405106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911405106</ArticleId><ArticleId IdType="pmc">PMC2791631</ArticleId><ArticleId IdType="pubmed">19933335</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang I, Nelson JK, &amp; DeVries GH (2005). c-Kit receptor expression in normal human Schwann cells and Schwann cell lines derived from neurofibromatosis type 1 tumors. J Neurosci Res, 82(4), 465&#x2013;471. doi:10.1002/jnr.20648</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20648</ArticleId><ArticleId IdType="pubmed">16235251</ArticleId></ArticleIdList></Reference><Reference><Citation>De ilippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K, &#x2026; Hogg N. (2013). Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood, 121(24), 4930&#x2013;4937. doi:10.1182/blood-2013-02-486217</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-02-486217</ArticleId><ArticleId IdType="pubmed">23645836</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng B, Lv W, Duan W, Liu Y, Li Z, Ma Y, &#x2026; Li, C. (2018). Progressive Degeneration and Inhibition of Peripheral Nerve Regeneration in the SOD1- G93A Mouse Model of Amyotrophic Lateral Sclerosis. Cell Physiol Biochem, 46(6), 2358&#x2013;2372. doi:10.1159/000489627</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000489627</ArticleId><ArticleId IdType="pubmed">29742495</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubreuil P, Letard S, Ciufolini M, Gros L, Humbert M, Casteran N, &#x2026; Hermine O. (2009). Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT. PLoS One, 4(9), e7258. doi:10.1371/journal.pone.0007258</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0007258</ArticleId><ArticleId IdType="pmc">PMC2746281</ArticleId><ArticleId IdType="pubmed">19789626</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito B, De Santis A, Monteforte R, &amp; Baccari GC (2002). Mast cells in Wallerian degeneration: morphologic and ultrastructural changes. J Comp Neurol, 445(3), 199&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">11920701</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, &#x2026; Glass JD (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol, 185(2), 232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, &amp; Glass JD (2007). Axonal degeneration in motor neuron disease. Neurodegener Dis, 4(6), 431&#x2013;442. doi:10.1159/000107704</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000107704</ArticleId><ArticleId IdType="pubmed">17934327</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, Schneider C, Xu L, Borg J, Spooren W, &amp; Caroni P. (2000). Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci, 20(7), 2534&#x2013;2542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Galli SJ, Tsai M, &amp; Wershil BK (1993). The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol, 142(4), 965&#x2013;974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886888</ArticleId><ArticleId IdType="pubmed">7682764</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Sanchez JA, Pilch KS, van der Lans M, Fazal SV, Benito C, Wagstaff LJ, &#x2026; Jessen KR (2017). After Nerve Injury, Lineage Tracing Shows That Myelin and Remak Schwann Cells Elongate Extensively and Branch to Form Repair Schwann Cells, Which Shorten Radically on Remyelination. J Neurosci, 37(37), 9086&#x2013;9099. doi:10.1523/JNEUROSCI.1453-17.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1453-17.2017</ArticleId><ArticleId IdType="pmc">PMC5597985</ArticleId><ArticleId IdType="pubmed">28904214</ArticleId></ArticleIdList></Reference><Reference><Citation>Greter M, Lelios I, Pelczar P, Hoeffel G, Price J, Leboeuf M, &#x2026; Becher B. (2012). Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity, 37(6), 1050&#x2013;1060. doi:10.1016/j.immuni.2012.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.11.001</ArticleId><ArticleId IdType="pmc">PMC4291117</ArticleId><ArticleId IdType="pubmed">23177320</ArticleId></ArticleIdList></Reference><Reference><Citation>Groh J, Klein I, Hollmann C, Wettmarshausen J, Klein D, &amp; Martini R. (2015). CSF-1-activated macrophages are target-directed and essential mediators of Schwann cell dedifferentiation and dysfunction in Cx32-deficient mice. Glia, 63(6), 977&#x2013;986. doi:10.1002/glia.22796</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22796</ArticleId><ArticleId IdType="pubmed">25628221</ArticleId></ArticleIdList></Reference><Reference><Citation>Groh J, Weis J, Zieger H, Stanley ER, Heuer H, &amp; Martini R. (2012). Colony- stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X. Brain, 135(Pt 1), 88&#x2013;104. doi:10.1093/brain/awr283</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr283</ArticleId><ArticleId IdType="pmc">PMC3267979</ArticleId><ArticleId IdType="pubmed">22094537</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Z, Kuhn JA, Wang X, Colquitt B, Solorzano C, Vaman S, &#x2026; Basbaum AI (2016). Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain. Nat Neurosci, 19(1), 94&#x2013;101. doi:10.1038/nn.4189</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4189</ArticleId><ArticleId IdType="pmc">PMC4703328</ArticleId><ArticleId IdType="pubmed">26642091</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirata K, &amp; Kawabuchi M. (2002). Myelin phagocytosis by macrophages and nonmacrophages during Wallerian degeneration. Microsc Res Tech, 57(6), 541&#x2013;547. doi:10.1002/jemt.10108</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jemt.10108</ArticleId><ArticleId IdType="pubmed">12112437</ArticleId></ArticleIdList></Reference><Reference><Citation>Iemura A, Tsai M, Ando A, Wershil BK, &amp; Galli SJ (1994). The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol, 144(2), 321&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1887147</ArticleId><ArticleId IdType="pubmed">7508684</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito T, Smrz D, Jung MY, Bandara G, Desai A, Smrzova S, &#x2026; Gilfillan AM (2012). Stem cell factor programs the mast cell activation phenotype. J Immunol, 188(11), 5428&#x2013;5437. doi:10.4049/jimmunol.1103366</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1103366</ArticleId><ArticleId IdType="pmc">PMC3358494</ArticleId><ArticleId IdType="pubmed">22529299</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen KR, &amp; Arthur-Farraj P. (2019). Repair Schwann cell update: Adaptive reprogramming, EMT, and stemness in regenerating nerves. Glia, 67(3), 421&#x2013;437. doi:10.1002/glia.23532</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23532</ArticleId><ArticleId IdType="pubmed">30632639</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen KR, &amp; Mirsky R. (2016). The repair Schwann cell and its function in regenerating nerves. J Physiol, 594(13), 3521&#x2013;3531. doi:10.1113/JP270874</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP270874</ArticleId><ArticleId IdType="pmc">PMC4929314</ArticleId><ArticleId IdType="pubmed">26864683</ArticleId></ArticleIdList></Reference><Reference><Citation>Kano O, Beers DR, Henkel JS, &amp; Appel SH (2012). Peripheral nerve inflammation in ALS mice: cause or consequence. Neurology, 78(11), 833&#x2013;835. doi:10.1212/WNL.0b013e318249f776</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318249f776</ArticleId><ArticleId IdType="pmc">PMC3304948</ArticleId><ArticleId IdType="pubmed">22377817</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller AF, Gravel M, &amp; Kriz J. (2009). Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells. Glia, 57(10), 1130&#x2013;1142. doi:10.1002/glia.20836</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20836</ArticleId><ArticleId IdType="pubmed">19115383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennel PF, Finiels F, Revah F, &amp; Mallet J. (1996). Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: an electromyographic study. Neuroreport, 7(8), 1427&#x2013;1431.</Citation><ArticleIdList><ArticleId IdType="pubmed">8856691</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerkhoff H, Troost D, Louwerse ES, van Dijk M, Veldman H, &amp; Jennekens FG (1993). Inflammatory cells in the peripheral nervous system in motor neuron disease. Acta Neuropathol, 85(5), 560&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">8493864</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein D, &amp; Martini R. (2016). Myelin and macrophages in the PNS: An intimate relationship in trauma and disease. Brain Res, 1641(Pt A), 130&#x2013;138. doi:10.1016/j.brainres.2015.11.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.11.033</ArticleId><ArticleId IdType="pubmed">26631844</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein D, Patzko A, Schreiber D, van Hauwermeiren A, Baier M, Groh J, &#x2026; Martini R. (2015). Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice. Brain, 138(Pt 11), 3193&#x2013;3205. doi:10.1093/brain/awv240</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv240</ArticleId><ArticleId IdType="pubmed">26297559</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J, &amp; Xu Z. (1998). Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci, 18(9), 3241&#x2013;3250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792665</ArticleId><ArticleId IdType="pubmed">9547233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindborg JA, Mack M, &amp; Zigmond RE (2017). Neutrophils Are Critical for Myelin Removal in a Peripheral Nerve Injury Model of Wallerian Degeneration. J Neurosci, 37(43), 10258&#x2013;10277. doi:10.1523/JNEUROSCI.2085-17.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2085-17.2017</ArticleId><ArticleId IdType="pmc">PMC5656991</ArticleId><ArticleId IdType="pubmed">28912156</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobsiger CS, Boillee S, McAlonis-Downes M, Khan AM, Feltri ML, Yamanaka K, &amp; Cleveland DW (2009). Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc Natl Acad Sci U S A, 106(11), 4465&#x2013;4470. doi:10.1073/pnas.0813339106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0813339106</ArticleId><ArticleId IdType="pmc">PMC2657393</ArticleId><ArticleId IdType="pubmed">19251638</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J, Elwood F, Britschgi M, Villeda S, Zhang H, Ding Z, &#x2026; Wyss-Coray, T. (2013). Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. J Exp Med, 210(1), 157&#x2013;172. doi:10.1084/jem.20120412</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20120412</ArticleId><ArticleId IdType="pmc">PMC3549715</ArticleId><ArticleId IdType="pubmed">23296467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma D, Wang B, Zawadzka M, Gonzalez G, Wu Z, Yu B, &#x2026; Zhao, C. (2018). A Subpopulation of Foxj1-Expressing, Nonmyelinating Schwann Cells of the Peripheral ervous System Contribute to Schwann Cell Remyelination in the Central Nervous System. J Neurosci, 38(43), 9228&#x2013;9239. doi:10.1523/JNEUROSCI.0585-18.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0585-18.2018</ArticleId><ArticleId IdType="pmc">PMC6199410</ArticleId><ArticleId IdType="pubmed">30228229</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Muriana A, Mancuso R, Francos-Quijorna I, Olmos-Alonso A, Osta R, Perry VH, &#x2026; Lopez-Vales R. (2016). CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves. Sci Rep, 6, 25663. doi:10.1038/srep25663</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25663</ArticleId><ArticleId IdType="pmc">PMC4865981</ArticleId><ArticleId IdType="pubmed">27174644</ArticleId></ArticleIdList></Reference><Reference><Citation>Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, &amp; Galli SJ (2007). Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev, 217, 304&#x2013;328. doi:10.1111/j.1600-065X.2007.00520.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2007.00520.x</ArticleId><ArticleId IdType="pubmed">17498068</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S, &amp; Julien JP (2013). Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci, 14(3), 161&#x2013;176. doi:10.1038/nrn3380</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3380</ArticleId><ArticleId IdType="pubmed">23361386</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora J, Genge A, Chio A, Estol CJ, Chaverri D, Hernandez M., &#x2026; Group AS (2019). Masitinib as an Add-on Therapy to Riluzole in Patients with Amyotrophic Lateral Sclerosis: A Randomised Clinical Trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. doi:10.1080/21678421.2019.1632346</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1632346</ArticleId><ArticleId IdType="pubmed">31280619</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandi S, Cioce M, Yeung YG, Nieves E, Tesfa L, Lin H, &#x2026; Stanley ER (2013). Receptor-type protein-tyrosine phosphatase zeta is a functional receptor for interleukin-34. J Biol Chem, 288(30), 21972&#x2013;21986. doi:10.1074/jbc.M112.442731</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.442731</ArticleId><ArticleId IdType="pmc">PMC3724651</ArticleId><ArticleId IdType="pubmed">23744080</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G, Trolese MC, de Vito G, Cecchi R, Riva N, Dina G, &#x2026; Bendotti C. (2016a). Immune response in peripheral axons delays disease progression in SOD1(G93A) mice. J Neuroinflammation, 13(1), 261. doi:10.1186/s12974-016-0732-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0732-2</ArticleId><ArticleId IdType="pmc">PMC5055725</ArticleId><ArticleId IdType="pubmed">27717377</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G, Trolese MC, de Vito G, Cecchi R, Riva N, Dina G, &#x2026; Bendotti C. (2016b). Immune response in peripheral axons delays disease. J Neuroinflammation, 13(1), 261. doi:10.1186/s12974-016-0732-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0732-2</ArticleId><ArticleId IdType="pmc">PMC5055725</ArticleId><ArticleId IdType="pubmed">27717377</ArticleId></ArticleIdList></Reference><Reference><Citation>Okubo M, Yamanaka H, Kobayashi K, Dai Y, Kanda H, Yagi H, &amp; Noguchi K. (2016). Macrophage-Colony Stimulating Factor Derived from Injured Primary Afferent Induces Proliferation of Spinal Microglia and Neuropathic Pain in Rats. PLoS One, 11(4), e0153375. doi:10.1371/journal.pone.0153375</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0153375</ArticleId><ArticleId IdType="pmc">PMC4829214</ArticleId><ArticleId IdType="pubmed">27071004</ArticleId></ArticleIdList></Reference><Reference><Citation>Olmos-Alonso A, Schetters ST, Sri S, Askew K, Mancuso R, Vargas-Caballero M, &#x2026; Gomez-Nicola D. (2016). Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer&#x2019;s-like pathology. Brain, 139(Pt 3), 891&#x2013;907. doi:10.1093/brain/awv379</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv379</ArticleId><ArticleId IdType="pmc">PMC4766375</ArticleId><ArticleId IdType="pubmed">26747862</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva N, Clarelli F, Domi T, Cerri F, Gallia F, Trimarco A, &#x2026; Quattrini A. (2016). Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: insights into pathogenesis. Sci Rep, 6, 39297. doi:10.1038/srep39297</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep39297</ArticleId><ArticleId IdType="pmc">PMC5159906</ArticleId><ArticleId IdType="pubmed">27982123</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanley ER, &amp; Chitu V. (2014). CSF-1 receptor signaling in myeloid cells. Cold Spring Harb Perspect Biol, 6(6). doi:10.1101/cshperspect.a021857</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a021857</ArticleId><ArticleId IdType="pmc">PMC4031967</ArticleId><ArticleId IdType="pubmed">24890514</ArticleId></ArticleIdList></Reference><Reference><Citation>Staser K, Yang FC, &amp; Clapp DW (2010). Mast cells and the neurofibroma microenvironment. Blood, 116(2), 157&#x2013;164. doi:10.1182/blood-2009-09-242875</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2009-09-242875</ArticleId><ArticleId IdType="pmc">PMC2910605</ArticleId><ArticleId IdType="pubmed">20233971</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoll G, Griffin JW, Li CY, &amp; Trapp BD (1989). Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol, 18(5), 671&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pubmed">2614485</ArticleId></ArticleIdList></Reference><Reference><Citation>Stratton JA, Holmes A, Rosin NL, Sinha S, Vohra M, Burma NE, &#x2026; Biernaskie J. (2018). Macrophages Regulate Schwann Cell Maturation after Nerve Injury. Cell Rep, 24(10), 2561&#x2013;2572 e2566. doi:10.1016/j.celrep.2018.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.08.004</ArticleId><ArticleId IdType="pubmed">30184491</ArticleId></ArticleIdList></Reference><Reference><Citation>Tofaris GK, Patterson PH, Jessen KR, &amp; Mirsky R. (2002). Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci, 22(15), 6696&#x2013;6703. doi:20026699</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758146</ArticleId><ArticleId IdType="pubmed">12151548</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomlinson JE, Zygelyte E, Grenier JK, Edwards MG, &amp; Cheetham J. (2018). Temporal changes in macrophage phenotype after peripheral nerve injury. J Neuroinflammation, 15(1), 185. doi:10.1186/s12974-018-1219-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1219-0</ArticleId><ArticleId IdType="pmc">PMC6003127</ArticleId><ArticleId IdType="pubmed">29907154</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, Ibarburu S, Barreto-Nunez R, Babdor J, Maciel TT, Guillo M, &#x2026; Barbeito L. (2016). Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis. J Neuroinflammation, 13(1), 177. doi:10.1186/s12974-016-0620-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0620-9</ArticleId><ArticleId IdType="pmc">PMC4940876</ArticleId><ArticleId IdType="pubmed">27400786</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, Ibarburu S, Barreto-Nunez R, Varela V, Moura IC, Dubreuil P, &#x2026; Barbeito L. (2017). Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS. JCI Insight, 2(20). doi:10.1172/jci.insight.95934</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.95934</ArticleId><ArticleId IdType="pmc">PMC5846907</ArticleId><ArticleId IdType="pubmed">29046475</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, King PH, Si Y, Kwon Y, Varela V, Ibarburu S, &#x2026; Barbeito L. (2018). Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight, 3(19). doi:10.1172/jci.insight.123249</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.123249</ArticleId><ArticleId IdType="pmc">PMC6237484</ArticleId><ArticleId IdType="pubmed">30282815</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dyke JM, Smit-Oistad IM, Macrander C, Krakora D, Meyer MG, &amp; Suzuki M. (2016). Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS). Exp Neurol, 277, 275&#x2013;282. doi:10.1016/j.expneurol.2016.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.01.008</ArticleId><ArticleId IdType="pmc">PMC4762214</ArticleId><ArticleId IdType="pubmed">26775178</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, Cella M, &#x2026; Colonna, (2012). IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol, 13(8), 753&#x2013;760. doi:10.1038/ni.2360</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2360</ArticleId><ArticleId IdType="pmc">PMC3941469</ArticleId><ArticleId IdType="pubmed">22729249</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>